Alveolar type 2 epithelial cell senescence and radiation-induced pulmonary fibrosis

Radiation-induced pulmonary fibrosis (RIPF) is a chronic and progressive respiratory tract disease characterized by collagen deposition. The pathogenesis of RIPF is still unclear. Type 2 alveolar epithelial cells (AT2), the essential cells that maintain the structure and function of lung tissue, are...

Full description

Bibliographic Details
Main Authors: Shenghui Zhou, Jiaojiao Zhu, Ping-Kun Zhou, Yongqing Gu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2022.999600/full
_version_ 1811326690302885888
author Shenghui Zhou
Shenghui Zhou
Jiaojiao Zhu
Ping-Kun Zhou
Ping-Kun Zhou
Yongqing Gu
Yongqing Gu
author_facet Shenghui Zhou
Shenghui Zhou
Jiaojiao Zhu
Ping-Kun Zhou
Ping-Kun Zhou
Yongqing Gu
Yongqing Gu
author_sort Shenghui Zhou
collection DOAJ
description Radiation-induced pulmonary fibrosis (RIPF) is a chronic and progressive respiratory tract disease characterized by collagen deposition. The pathogenesis of RIPF is still unclear. Type 2 alveolar epithelial cells (AT2), the essential cells that maintain the structure and function of lung tissue, are crucial for developing pulmonary fibrosis. Recent studies indicate the critical role of AT2 cell senescence during the onset and progression of RIPF. In addition, clearance of senescent AT2 cells and treatment with senolytic drugs efficiently improve lung function and radiation-induced pulmonary fibrosis symptoms. These findings indicate that AT2 cell senescence has the potential to contribute significantly to the innovative treatment of fibrotic lung disorders. This review summarizes the current knowledge from basic and clinical research about the mechanism and functions of AT2 cell senescence in RIPF and points to the prospects for clinical treatment by targeting senescent AT2 cells.
first_indexed 2024-04-13T14:54:12Z
format Article
id doaj.art-28fa4b4c43084de180b18f768169ea64
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-04-13T14:54:12Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-28fa4b4c43084de180b18f768169ea642022-12-22T02:42:30ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2022-11-011010.3389/fcell.2022.999600999600Alveolar type 2 epithelial cell senescence and radiation-induced pulmonary fibrosisShenghui Zhou0Shenghui Zhou1Jiaojiao Zhu2Ping-Kun Zhou3Ping-Kun Zhou4Yongqing Gu5Yongqing Gu6Hengyang Medical College, University of South China, Hengyang, ChinaBeijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, AMMS, Beijing, ChinaBeijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, AMMS, Beijing, ChinaHengyang Medical College, University of South China, Hengyang, ChinaBeijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, AMMS, Beijing, ChinaHengyang Medical College, University of South China, Hengyang, ChinaBeijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, AMMS, Beijing, ChinaRadiation-induced pulmonary fibrosis (RIPF) is a chronic and progressive respiratory tract disease characterized by collagen deposition. The pathogenesis of RIPF is still unclear. Type 2 alveolar epithelial cells (AT2), the essential cells that maintain the structure and function of lung tissue, are crucial for developing pulmonary fibrosis. Recent studies indicate the critical role of AT2 cell senescence during the onset and progression of RIPF. In addition, clearance of senescent AT2 cells and treatment with senolytic drugs efficiently improve lung function and radiation-induced pulmonary fibrosis symptoms. These findings indicate that AT2 cell senescence has the potential to contribute significantly to the innovative treatment of fibrotic lung disorders. This review summarizes the current knowledge from basic and clinical research about the mechanism and functions of AT2 cell senescence in RIPF and points to the prospects for clinical treatment by targeting senescent AT2 cells.https://www.frontiersin.org/articles/10.3389/fcell.2022.999600/fullradiation-induced pulmonary fibrosistype 2 alveolar epithelial cellscellular senescencesenescence associated secretory phenotypetherapy
spellingShingle Shenghui Zhou
Shenghui Zhou
Jiaojiao Zhu
Ping-Kun Zhou
Ping-Kun Zhou
Yongqing Gu
Yongqing Gu
Alveolar type 2 epithelial cell senescence and radiation-induced pulmonary fibrosis
Frontiers in Cell and Developmental Biology
radiation-induced pulmonary fibrosis
type 2 alveolar epithelial cells
cellular senescence
senescence associated secretory phenotype
therapy
title Alveolar type 2 epithelial cell senescence and radiation-induced pulmonary fibrosis
title_full Alveolar type 2 epithelial cell senescence and radiation-induced pulmonary fibrosis
title_fullStr Alveolar type 2 epithelial cell senescence and radiation-induced pulmonary fibrosis
title_full_unstemmed Alveolar type 2 epithelial cell senescence and radiation-induced pulmonary fibrosis
title_short Alveolar type 2 epithelial cell senescence and radiation-induced pulmonary fibrosis
title_sort alveolar type 2 epithelial cell senescence and radiation induced pulmonary fibrosis
topic radiation-induced pulmonary fibrosis
type 2 alveolar epithelial cells
cellular senescence
senescence associated secretory phenotype
therapy
url https://www.frontiersin.org/articles/10.3389/fcell.2022.999600/full
work_keys_str_mv AT shenghuizhou alveolartype2epithelialcellsenescenceandradiationinducedpulmonaryfibrosis
AT shenghuizhou alveolartype2epithelialcellsenescenceandradiationinducedpulmonaryfibrosis
AT jiaojiaozhu alveolartype2epithelialcellsenescenceandradiationinducedpulmonaryfibrosis
AT pingkunzhou alveolartype2epithelialcellsenescenceandradiationinducedpulmonaryfibrosis
AT pingkunzhou alveolartype2epithelialcellsenescenceandradiationinducedpulmonaryfibrosis
AT yongqinggu alveolartype2epithelialcellsenescenceandradiationinducedpulmonaryfibrosis
AT yongqinggu alveolartype2epithelialcellsenescenceandradiationinducedpulmonaryfibrosis